Hauth JC, Cunningham FG, Whalley PJ. Early labor initiation with oral PGE2 after prematurerupture of the membranes at term. Obstet Gynecol 1977;49(5):523-6.Haverkamp AD, Orleans M, Langendoerfer S, McFee J, Murphy J, Thompson HE. A controlledtrial of the differential effects of intrapartum fetal monitoring. Am J Obstet Gynecol1979;134(4):399-412.Haverkamp AD, Thompson HE, McFee JG, Cetrulo C. The evaluation of continuous fetal heartrate monitoring in high-risk pregnancy. Am J Obstet Gynecol 1976;125(3):310-20.Head BB, Owen J, Vincent RD Jr, Shih G, Chestnut DH, Hauth JC. A randomized trial ofintrapartum analgesia in women with severe preeclampsia. Obstet Gynecol2002;99(3):452-7.Heimstad R, Skogvoll E, Mattsson LA, Johansen OJ, Eik-Nes SH, Salvesen KA. In<strong>du</strong>ction oflabor or serial antenatal fetal monitoring in postterm pregnancy: A randomized controlledtrial. Obstet Gynecol 2007a;109(3):609-17.Heimstad R, Romundstad PR, Hyett J, Mattsson LA, Salvesen KA. Women's experiences andattitudes towards expectant management and in<strong>du</strong>ction of labor for post-term pregnancy.Acta Obstet Gynecol Scand 2007b;86(8):950-6.Heinzl S, Ramzin MS, Schneider M, Luescher KP. [Priming of cervix with prostaglandin gel<strong>du</strong>ring immature birth situation at term (author's transl)]. Z Geburtshilfe Perinatol1980;184(6):395-400.Hemminki E, Heikkila K, Sevon T, Koponen P. Special features of health services and registerbased trials – experiences from a randomized trial of childbirth classes. BMC Health ServRes 2008;8:126.Hemminki E, Virta A-L, Koponen P, Malin M, Kojo-Austin H, Tuimala R. A trial on continuoushuman support <strong>du</strong>ring labor: Feasibility, interventions and mothers' satisfaction (The1987 trial). J Psychosom Obstet Gynaecol 1990a;11(4):239-50.Hemminki E, Virta A-L, Koponen P, Malin M, Kojo-Austin H, Tuimala R. A trial on continuoushuman support <strong>du</strong>ring labor: Feasibility, interventions and mothers' satisfaction (The1988 trial). J Psychosom Obstet Gynaecol 1990b;11(4):239-50.Henry GR. A controlled trial of surgical in<strong>du</strong>ction of labour and amnioscopy in the managementof prolonged pregnancy. J Obstet Gynaecol Br Commonw 1969;76(9):795-8.Herbst A et Ingemarsson I. Intermittent versus continuous electronic monitoring in labour: Arandomised study. Br J Obstet Gynaecol 1994;101(8):663-8.Hidar S, Bibi M, Jerbi M, Bouguizene S, Nouira M, Mellouli R, et al. Apport de l'administrationintracervicale de PGE2 dans les ruptures prématurées des membranes à terme. Essaiclinique prospectif randomisé. J Gynecol Obstet Biol Reprod (Paris) 2000;29(6):607-13.Hjelmstedt A, Shenoy ST, Stener-Victorin E, Lekander M, Bhat M, Balakumaran L,Waldenstrom U. Acupressure to re<strong>du</strong>ce labor pain: A randomized controlled trial. ActaObstet Gynecol Scand 2010;89(11):1453-9.176
Hjertberg R, Hammarstrom M, Moberger B, Nordlander E, Granstrom L. Premature rupture ofthe membranes (PROM) at term in nulliparous women with a ripe cervix. A randomizedtrial of 12 or 24 hours of expectant management. Acta Obstet Gynecol Scand1996;75(1):48-53.Hodnett ED et Osborn RW. Effects of continuous intrapartum professional support on childbirthoutcomes. Res Nurs Health 1989;12(5):289-97.Hodnett ED, Gates S, Hofmeyr GJ, Sakala C, Weston J. Continuous support for women <strong>du</strong>ringchildbirth. Cochrane Database Syst Rev 2011;(2):CD003766.Hodnett ED, Lowe NK, Hannah ME, Willan AR, Stevens B, Weston JA, et al. Effectiveness ofnurses as providers of birth labor support in North American hospitals: A randomizedcontrolled trial. JAMA 2002;288(11):1373-81.Hoffmann RA, Anthony J, Fawcus S. Oral misoprostol vs. placebo in the management of prelaborrupture of membranes at term. Int J Gynaecol Obstet 2001;72(3):215-21.Hofmeyr GJ, Barrett JF, Crowther CA. Planned caesarean section for women with a twinpregnancy. Cochrane Database Syst Rev 2011;(12):CD006553.Hofmeyr GJ, Gülmezoglu AM, Pileggi C. Vaginal misoprostol for cervical ripening and in<strong>du</strong>ctionof labour. Cochrane Database Syst Rev 2010;(10):CD000941.Hofmeyr GJ, Hannah M, Lawrie TA. Planned caesarean section for term breech delivery.Cochrane Database Syst Rev 2003;(3):CD000166.Hofmeyr GJ, Nikodem VC, Wolman WL, Chalmers BE, Kramer T. Companionship to modifythe clinical birth environment: Effects on progress and perceptions of labour, andbreastfeeding. Br J Obstet Gynaecol 1991;98(8):756-64.Hogg B, Owen J, Shih G, Vince R, Chestnut D, Hauth JC. A randomised control trial ofintrapartum analgesia in women with severe preeclampsia. Am J Obstet Gynecol2000;182:S148.Homer CS, Davis GK, Brodie PM, Sheehan A, Barclay LM, Wills J, Chapman MG.Collaboration in maternity care: A randomised controlled trial comparing communitybasedcontinuity of care with standard hospital care. BJOG 2001;108(1):16-22.Hook B, Kiwi R, Amini SB, Fanaroff A, Hack M. Neonatal morbidity after elective repeatcesarean section and trial of labor. Pediatrics 1997;100(3 Pt 1):348-53.Horey D, Weaver J, Russell H. Information for pregnant women about caesarean birth. CochraneDatabase Syst Rev 2004;(1):CD003858.Howarth GR et Botha DJ. Amniotomy plus intravenous oxytocin for in<strong>du</strong>ction of labour.Cochrane Database Syst Rev 2001;(3):CD003250.Howell CJ, Kidd C, Roberts W, Upton P, Lucking L, Jones PW, Johanson RB. A randomisedcontrolled trial of epi<strong>du</strong>ral compared with non-epi<strong>du</strong>ral analgesia in labour. BJOG2001;108(1):27-33.177
- Page 1 and 2:
ANNEXES DU RAPPORTMesures prometteu
- Page 3 and 4:
Tableau B-6 Les études cliniques i
- Page 5 and 6:
PubMedSURVEILLANCE FŒTALE ÉLECTRO
- Page 7 and 8:
PubMedACCÉLÉRATION DU TRAVAILRech
- Page 9 and 10:
De plus, en utilisant les mêmes co
- Page 11:
Tableau B-2b Les essais cliniques r
- Page 14 and 15:
Evron, 2007Shifman, 2007Nafisi, 200
- Page 16 and 17:
Jozwiak, 2012Hussain, 2011Hofmeyr,
- Page 18 and 19:
Jozwiak, 2012Hussain, 2011Hofmeyr,
- Page 20 and 21:
Jozwiak, 2012Hussain, 2011Hofmeyr,
- Page 22 and 23:
Tableau B-7 Les études cliniques i
- Page 24 and 25:
Thurnau, 1991 (P)xPickhardt, 1992 (
- Page 26 and 27:
REVUESSYSTÉMATIQUESCARACTÉRISTIQU
- Page 28 and 29:
REVUESSYSTÉMATIQUESLiu et Sia, 200
- Page 30 and 31:
Tableau C-4 La description des revu
- Page 32 and 33:
REVUESSYSTÉMATIQUESCARACTÉRISTIQU
- Page 34 and 35:
REVUESSYSTÉMATIQUESCARACTÉRISTIQU
- Page 36 and 37:
REVUESSYSTÉMATIQUESWei, 2009aCanad
- Page 38 and 39:
Tableau C-6 La description des revu
- Page 40 and 41:
Tableau C-7 La description des revu
- Page 42 and 43:
REVUESSYSTÉMATIQUESKhunpradit, 201
- Page 44 and 45:
ANNEXE D CARACTÉRISTIQUES DES ÉTU
- Page 46 and 47:
REVUESSYSTÉMATIQUESHowarth et Bota
- Page 48 and 49:
ANNEXE E RECENSEMENT DES ÉLÉMENTS
- Page 50 and 51:
Conditions INTRApartum jamaisinclus
- Page 52 and 53:
ANNEXE F EXERCICES D’INTERPRÉTAT
- Page 54 and 55:
F.1 ANALGÉSIE PÉRIDURALEF.1.1 EXE
- Page 56 and 57:
3. Les implications sur la pratique
- Page 58 and 59:
5. Les enjeux éthiquesPeut-il y av
- Page 60 and 61:
F.1.2 SOMMAIRE DES COMMENTAIRES RE
- Page 62 and 63:
Question 3Les implications sur la p
- Page 64 and 65:
Question 4Facilitateurs pour les al
- Page 66 and 67:
Éléments de mesureConcernant la p
- Page 68 and 69:
F.2 SURVEILLANCE FŒTALE ÉLECTRONI
- Page 70 and 71:
4. Les implications sur la pratique
- Page 72 and 73:
6. Les enjeux éthiquesSi on vous d
- Page 74 and 75:
ENCERCLEZ les conditions antepartum
- Page 76 and 77:
Évaluation de l’exerciceMerci d
- Page 78 and 79:
Question 3Facteurs liés à la non-
- Page 80 and 81:
Question 5Avantages et inconvénien
- Page 82 and 83:
Question 6Arguments de nature éthi
- Page 84 and 85:
Éléments de mesuresConcernant la
- Page 86 and 87:
F.3 DÉCLENCHEMENT ET ACCÉLÉRATIO
- Page 88 and 89:
3. Des mesures pour optimiser le re
- Page 90 and 91:
Évaluation de l’exerciceMerci d
- Page 92 and 93:
Éviter l’analgésie périduralee
- Page 94 and 95:
péridurale.Manque de préparation
- Page 96 and 97:
Considérant que le déclenchement
- Page 98 and 99:
4. Les enjeux éthiquesIniquités d
- Page 100 and 101:
F.4 CÉSARIENNEF.4.1 EXERCICE D’I
- Page 102 and 103:
3. Les implications sur la pratique
- Page 104 and 105:
5. Les enjeux éthiquesIniquités d
- Page 106 and 107:
F.4.2 SOMMAIRE DES COMMENTAIRES RE
- Page 108 and 109:
Question 3Les implications sur la p
- Page 110 and 111:
Question 4Facilitateurs et barrièr
- Page 112 and 113:
Éléments pour mesures (spécifiqu
- Page 114 and 115:
ANNEXE G TRAVAUX AVEC LE COMITÉ DE
- Page 116 and 117:
Programme9 h 30-10 h 00 Accueil et
- Page 118 and 119:
OUTIL DE CONSULTATION1. Cotez de 1
- Page 120 and 121:
accompagnant spécialement formé
- Page 122 and 123:
PertinenceAcceptabilitéFaisabilit
- Page 124 and 125:
PertinenceAcceptabilitéFaisabilit
- Page 126 and 127:
PertinenceAcceptabilitéFaisabilit
- Page 128 and 129:
Bloc 2 : la surveillance fœtale é
- Page 130 and 131: PertinenceAcceptabilitéFaisabilit
- Page 132 and 133: PertinenceAcceptabilitéFaisabilit
- Page 134 and 135: La surveillance fœtale électroniq
- Page 136 and 137: Dans les grossesses à terme et à
- Page 138 and 139: PertinenceAcceptabilitéFaisabilit
- Page 140 and 141: Considérant que l’accélération
- Page 142 and 143: 19691987200120062009Bloc 4 : la cé
- Page 144 and 145: Contribution au taux général de c
- Page 146 and 147: (2001) et de diffuser périodiqueme
- Page 148 and 149: Mesures pour réduire le recours à
- Page 150 and 151: La césarienne2. Suggestions pour d
- Page 152 and 153: culture de la naissance. C’est au
- Page 154 and 155: contrer la tendance à recourir aux
- Page 156 and 157: FACTEURS ASSOCIÉS : Sensibiliser l
- Page 158 and 159: 154- (ce libellé est) contre-produ
- Page 160 and 161: BLOC 3 - Déclenchement / accélér
- Page 162 and 163: BLOC 4 - CésarienneGÉNÉRAL - MIS
- Page 164 and 165: FACTEURS ASSOCIÉS - GÉNÉRAL : Fa
- Page 166 and 167: Ocytocine pour déclenchement du tr
- Page 168 and 169: Support 1 : 1 (Hodnett, 2011)Nombre
- Page 170 and 171: Anim-Somuah M, Smyth RM, Jones L. E
- Page 172 and 173: Bugg GJ, Siddiqui F, Thornton JG. O
- Page 174 and 175: Cogan R et Spinnato JA. Social supp
- Page 176 and 177: El-Torkey M et Grant JM. Sweeping o
- Page 178 and 179: Gourounti K et Sandall J. Admission
- Page 182 and 183: Huang XH, Xiang XY, Shen RG, Shang
- Page 184 and 185: Larmon JE, Magann EF, Dickerson GA,
- Page 186 and 187: MacKenzie IZ, Bradley S, Embrey MP.
- Page 188 and 189: Morales WJ et Lazar AJ. Expectant m
- Page 190 and 191: Ozden S, Delikara MN, Avci A, Ficic
- Page 192 and 193: Roberts WE, North DH, Speed JE, Mar
- Page 194 and 195: Shifman EM, Butrov AV, Floka SE, Go
- Page 196 and 197: Thorp JA, Hu DH, Albin RM, McNitt J
- Page 198: Witoonpanich P et Surapong K. Contr